Zhejiang Xinguang Pharmaceutical Hits Day High with 8.09% Surge

Zhejiang Xinguang Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 8.09% on July 13, 2026. The stock reached an intraday high of CNY 13.93, marking a notable achievement in a challenging market environment. In comparison, the China Shanghai Composite index declined by 2.06% on the same day, highlighting the stock's relative strength. Over the past week, Zhejiang Xinguang has shown a 4.49% increase, while its one-month performance stands at 3.53%. However, the company has faced challenges in the longer term, with a one-year performance of -12.34% and a three-year decline of 16.67%. Despite these setbacks, the company reported positive operational metrics, including a record operating cash flow of CNY 85.04 million and a significant reduction in raw material costs by 28.39% year-over-year. With a market capitalization of CNY 1,296 million, Zhejiang Xinguang operates within the pharmaceuticals and biotechnology sector, characterized by a price-to-earnings ratio of 23.00 and a dividend yield of 3.70%. The company's return on equity stands at 6.48%, reflecting its current financial positioning amidst broader market trends.